Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 441–460 of 17,898 drug recalls

Drug Recall Ongoing 2026 recordClass II

Testosterone, 303 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1303-01.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 100 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-1100-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 87.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1087-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 62.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1062-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 50.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1050-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1037-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 25.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1025-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 18.0 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1018-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Testosterone, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1012-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3037-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 25 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3025-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 22 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3022-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 20 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3020-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 18 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 3521, NDC: 79559-3018-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL,15 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3015-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79599-3012-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 10 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3010-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

ESTRADIOL, 6 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3006-32.

by F.H. INVESTMENTS, Inc. (dba Asteria Health)

Reason
Presence of Foreign substance - potential presence of metal particulate matter
Recall initiated
January 26, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass III

Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.

by Unichem Pharmaceuticals USA Inc.

Reason
Tablets/Capsules Imprinted with Wrong ID
Recall initiated
January 21, 2026
Reported by FDA
February 18, 2026
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.